Arch Therapeutics Statistics
Total Valuation
ARTHQ has a market cap or net worth of 444. The enterprise value is 9.36 million.
| Market Cap | 444 |
| Enterprise Value | 9.36M |
Important Dates
The next estimated earnings date is Friday, May 9, 2025.
| Earnings Date | May 9, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
ARTHQ has 4.44 million shares outstanding. The number of shares has increased by 339.38% in one year.
| Current Share Class | n/a |
| Shares Outstanding | 4.44M |
| Shares Change (YoY) | +339.38% |
| Shares Change (QoQ) | -1.17% |
| Owned by Insiders (%) | 3.28% |
| Owned by Institutions (%) | 16.03% |
| Float | 4.30M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 0.00 |
| PB Ratio | -0.00 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -0.72 |
| EV / Sales | 63.16 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | -2.53 |
Financial Position
The company has a current ratio of 0.10
| Current Ratio | 0.10 |
| Quick Ratio | 0.00 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | -2.53 |
| Interest Coverage | -0.63 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | -199.27% |
| Return on Invested Capital (ROIC) | n/a |
| Return on Capital Employed (ROCE) | 37.59% |
| Revenue Per Employee | 18,520 |
| Profits Per Employee | -1.62M |
| Employee Count | 8 |
| Asset Turnover | 0.10 |
| Inventory Turnover | 0.07 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -99.99% in the last 52 weeks. The beta is 4.03, so ARTHQ's price volatility has been higher than the market average.
| Beta (5Y) | 4.03 |
| 52-Week Price Change | -99.99% |
| 50-Day Moving Average | 0.20 |
| 200-Day Moving Average | 0.36 |
| Relative Strength Index (RSI) | 18.91 |
| Average Volume (20 Days) | 3,334 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | 1.99 |
Income Statement
In the last 12 months, ARTHQ had revenue of 148,163 and -12.99 million in losses. Loss per share was -2.35.
| Revenue | 148,163 |
| Gross Profit | 58,642 |
| Operating Income | -4.72M |
| Pretax Income | -12.26M |
| Net Income | -12.99M |
| EBITDA | -4.72M |
| EBIT | -4.72M |
| Loss Per Share | -2.35 |
Balance Sheet
The company has 30,030 in cash and 9.39 million in debt, giving a net cash position of -9.36 million or -2.11 per share.
| Cash & Cash Equivalents | 30,030 |
| Total Debt | 9.39M |
| Net Cash | -9.36M |
| Net Cash Per Share | -2.11 |
| Equity (Book Value) | -12.56M |
| Book Value Per Share | -2.83 |
| Working Capital | -12.57M |
Cash Flow
In the last 12 months, operating cash flow was -3.70 million and capital expenditures -4,521, giving a free cash flow of -3.71 million.
| Operating Cash Flow | -3.70M |
| Capital Expenditures | -4,521 |
| Free Cash Flow | -3.71M |
| FCF Per Share | -0.83 |
Margins
| Gross Margin | 39.58% |
| Operating Margin | -3,186.90% |
| Pretax Margin | -8,276.47% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
ARTHQ does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -339.38% |
| Shareholder Yield | -339.38% |
| Earnings Yield | -2,926,277.03% |
| FCF Yield | -834,608.56% |
Stock Splits
The last stock split was on January 18, 2023. It was a reverse split with a ratio of 0.005.
| Last Split Date | Jan 18, 2023 |
| Split Type | Reverse |
| Split Ratio | 0.005 |
Scores
ARTHQ has an Altman Z-Score of -94.06. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -94.06 |
| Piotroski F-Score | n/a |